cyclosporine has been researched along with Cancer, Second Primary in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, B; Rout, P; Satish, R | 1 |
| Campistol, JM; Canha, C; Castells, A; Diekmann, F; Ferreira, R; Moya-Rull, D; Oppenheimer, F; Revuelta, I; Rovira, J | 1 |
| Chen, YT; Cheng, YT; Chiang, CY; Hsieh, HH; Wang, HB | 1 |
| Ades, L; Devergie, A; Esperou, H; Ferry, C; Gluckman, E; Mary, JY; Porcher, R; Ribaud, P; Robin, M; Socié, G; Traineau, R | 1 |
| Yanagisawa, T | 1 |
| Au, WY; Chan, GC; Ha, SY; Hon, C; Ma, SK; Wong, KF | 1 |
| Friend, P; Kreis, H; Mathew, T | 1 |
| Apostolidis, I; Arvanitopoulou, E; Asprogeraka, T; Bakiri, M; Giannakoulas, N; Kotsianidis, I; Marinakis, T; Matsouka, P; Pagoni, M; Papaioannou, M; Skandali, A; Spanoudakis, E; Tsatalas, K; Viniou, N; Yataganas, X; Zikos, P | 1 |
| Duncan, FJ; Kusewitt, DF; Oberyszyn, TM; Thomas-Ahner, JM; VanBuskirk, AM; Wulff, BC | 1 |
| Bechstein, WO; Guckelberger, O; Jonas, S; Neuhaus, P; Neuhaus, R; Neumann, U; Rayes, N; Serke, S; Tullius, SG | 1 |
| Born, G; Froschauer, R; Gralka, S; Hohenberger, W; Köckerling, F; Müller, V; Ott, R; Reck, T | 1 |
| Apperley, JF; Duell, T; Jacobsen, N; Kolb, HJ; Ljungman, P; Nekolla, E; Prentice, HG; Socié, G; Tichelli, A; Van Lint, MT; van Weel, M; Weiss, M; Wick, R | 1 |
| Arai, K; Fukayama, M; Imashuku, S; Ito, E; Kitazawa, J; Yokoyama, M | 1 |
| Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A | 1 |
| Amenábar, JJ; Gaínza, FJ; Gómez-Ullate, P; Lampreabe, I; Urbizu, JM; Zárraga, S | 1 |
3 review(s) available for cyclosporine and Cancer, Second Primary
| Article | Year |
|---|---|
Systemic chemotherapy as a new conservative treatment for intraocular retinoblastoma.
Topics: Antineoplastic Agents; Cryotherapy; Cyclosporine; Drug Resistance, Multiple; Drug Therapy; Eye Enucleation; Humans; Hyperthermia, Induced; Immunosuppressive Agents; Neoplasms, Second Primary; Radiotherapy; Retinal Neoplasms; Retinoblastoma | 2004 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2001 |
[Presentation of cancers in recipients of a solid-organ transplant].
Topics: Carcinogens; Cell Transformation, Neoplastic; Cyclosporine; Genetic Predisposition to Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Melanoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogenes; Postoperative Complications; Prevalence; Recurrence; Risk; Sarcoma, Kaposi; Skin Neoplasms; Transplantation; Tumor Virus Infections; Ultraviolet Rays | 2001 |
2 trial(s) available for cyclosporine and Cancer, Second Primary
| Article | Year |
|---|---|
Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Data Interpretation, Statistical; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Greece; Humans; Idarubicin; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Neoplasms, Second Primary; Remission Induction; Societies, Medical; Survival Analysis; Treatment Outcome | 2006 |
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Clinical Trials as Topic; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoma; Neoplasms, Second Primary; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Interleukin-2; Skin Neoplasms; Tacrolimus; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1997 |
10 other study(ies) available for cyclosporine and Cancer, Second Primary
| Article | Year |
|---|---|
Double primary carcinoma in a renal allograft recipient.
Topics: Allografts; Azathioprine; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Prednisolone; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.
Topics: Adenocarcinoma; Aged; Azathioprine; Biomarkers; Cyclosporine; Drug Substitution; Esophageal Neoplasms; Esophagectomy; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasm Proteins; Neoplasms, Second Primary; Phosphorylation; Postoperative Complications; Prednisone; Protein Processing, Post-Translational; Sarcoma, Kaposi; Signal Transduction; Sirolimus; Skin Neoplasms; TOR Serine-Threonine Kinases | 2015 |
The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients.
Topics: Adult; Azathioprine; Carcinoma, Transitional Cell; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Neoplasms, Second Primary; Postoperative Complications; Retrospective Studies; Urinary Bladder Neoplasms | 2002 |
Long-term outcome after bone marrow transplantation for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Female; Follow-Up Studies; Humans; Incidence; Infections; Male; Neoplasms, Second Primary; Retrospective Studies; Survival Analysis; Time Factors; Tissue Donors; Treatment Outcome; Whole-Body Irradiation | 2004 |
Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Cryosurgery; Cryotherapy; Cyclosporine; DNA-Binding Proteins; Enzyme Inhibitors; Eye Neoplasms; Female; Histone-Lysine N-Methyltransferase; Humans; Infant, Newborn; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Proto-Oncogenes; Remission Induction; Retinoblastoma; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Vincristine | 2004 |
Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies.
Topics: Chemoprevention; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Multicenter Studies as Topic; Neoplasms; Neoplasms, Second Primary; Retrospective Studies; Sirolimus; Skin Neoplasms | 2004 |
Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.
Topics: Animals; Antineoplastic Agents; Cell Count; Cyclosporine; Disease Progression; Female; Immunosuppressive Agents; Incidence; Lymph Nodes; Mast Cells; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neutrophils; Sirolimus; Skin; Skin Neoplasms; Transforming Growth Factor beta1; Tumor Burden; Ultraviolet Rays | 2008 |
Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Cytomegalovirus Infections; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Monitoring, Immunologic; Neoplasms, Second Primary; Opportunistic Infections; Postoperative Complications; Retrospective Studies | 1998 |
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Neoplasms, Second Primary; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors | 1999 |
Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Neoplasms, Second Primary | 2001 |